Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
Nikolaos Spyrou, Natalia G. Vallianou, Jona Kadillari, et al.
Seminars in Cancer Biology (2021) Vol. 73, pp. 356-376
Closed Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
Jasna Deluce, Saman Maleki Vareki, Ricardo Fernandes
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 12
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab
Lorena Incorvaia, Alessandra Dimino, Laura Algeri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Single-cell transcriptome analysis reveals immunosuppressive landscape in overweight and obese colorectal cancer
Guozhong Xiao, Yihui Zheng, Huaxian Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Clinical metabolomics: useful insights, perspectives and challenges
Μaria Dalamaga
Metabolism Open (2024) Vol. 22, pp. 100290-100290
Open Access | Times Cited: 2
Diet patterns, gut microbiota and metabolic disorders: Perspectives and challenges
Μaria Dalamaga, Christina Tsigalou
Metabolism Open (2024) Vol. 23, pp. 100310-100310
Open Access | Times Cited: 2
Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors
Xin Zhang, Huiqin Li, Xiupeng Lv, et al.
Life (2022) Vol. 12, Iss. 3, pp. 409-409
Open Access | Times Cited: 12
Microbiota in Health and Disease—Potential Clinical Applications
Matthias Laudes, Corinna Geisler, Nathalie Rohmann, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 3866-3866
Open Access | Times Cited: 13
Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
Konstantinos Avgerinos, Junli Liu, Μaria Dalamaga
Metabolism Open (2023) Vol. 17, pp. 100233-100233
Open Access | Times Cited: 5
The Effect of Body Mass Index on Melanoma Biology, Immunotherapy Efficacy, and Clinical Outcomes: A Narrative Review
Jente Jansen, Marjan Garmyn, Canan Güvenç
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6433-6433
Open Access | Times Cited: 1
Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease
Pranali Jadhav, Asha Thomas, Rabindra K. Nanda, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 12, pp. 1324-1333
Closed Access | Times Cited: 4
Gut mycobiome as a promising preventive and therapeutic target for metabolic disorders
Μaria Dalamaga, Liaoyuan Zheng, Junli Liu
Metabolism Open (2022) Vol. 13, pp. 100168-100168
Open Access | Times Cited: 7
The progress on the relationship between gut microbiota and immune checkpoint blockade in tumors
Haili Jiang, Yingquan Ye, Mingqi Wang, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 4, pp. 4446-4465
Closed Access | Times Cited: 3
Multiomics-based Analysis Reveals Differences in intratumoral microbiota and Prognostic in Gastric Cancer Patients with Different BMI
Kang Liu, Zhengchen Jiang, Yubo Ma, et al.
Research Square (Research Square) (2024)
Open Access
The Microbiota in Cancer: A Secondary Player or a Protagonist?
Ana María Gómez García, Francisco López‐Muñoz, Eduardo García‐Rico
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 7812-7831
Open Access
The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
Efstratios Kardalas, Aggeliki Paikopoulou, Dimitra A. Vassiliadi, et al.
Metabolism Open (2024) Vol. 23, pp. 100313-100313
Open Access
Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research
Katia Mangano, Aristidis Diamantopoulos, Natalia G. Vallianou, et al.
Metabolism Open (2024) Vol. 24, pp. 100320-100320
Open Access
Anti-Diabetic Therapies and Cancer: From Bench to Bedside
Dimitris Kounatidis, Natalia G. Vallianou, Ιrene Karampela, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1479-1479
Open Access
The Influence of Diet and Probiotics on the Response of Solid Tumours to Immunotherapy: Present and Future Perspectives
Alejandro Olivares-Hernández, Luis Figuero-Pérez, Rogelio González‐Sarmiento, et al.
Applied Sciences (2021) Vol. 11, Iss. 18, pp. 8445-8445
Open Access | Times Cited: 3
Special issue: Diet, lipids, and cancer: From Pathogenic mechanisms to potential therapeutic strategies
Marta Farràs, Joan Carles Escolà‐Gil
Seminars in Cancer Biology (2021) Vol. 73, pp. 1-3
Closed Access | Times Cited: 1
Previous Page - Page 2

Scroll to top